BurfordE. H., BurfordC. E.: Combined therapy for Peyronie's disease. J. Urol., 78; 265 (1957).
5.
CastaigneA.: Un facteur de diffusion différent des hyaluronidases (agissant sur l'acide chondroitine sulfurique). Anésth. Analg. Rénim., 16; 567 (1959).
6.
ColomboC., ComolliC.: La introduzione ionoforetica di un enzima diffusore negli edemi post-traumatici. Riabilitazione, 5; 85 (1972).
7.
CorbierA.: La Thiomucase en diélectrolyse. Sem. Hô. Sem. thér., 40; 91 (1964).
8.
DesanctisP. N., FureyC. A.Jr.: Steroid injection therapy for Peyronie's disease: a 10-year summary and review of 38 case. J. Urol., 97; 114 (1967).
9.
DonatiL., Taidelli PalmiziG. A.: Il trattamento delle cicatrici ipertrofiche e cheloidee mediante Thiomucase. Minerva chir. (in corso di stampa).
10.
DugoisP.: The action of ultrasonics on Peyronie's disease, accelerated by alpha-chymotrypsin. Lyon méd., 93; 238 (1961).
11.
EkstromT., HultengrenN.: Peyronie's disease (plastic induratio of penis): treatment by local injections of prednisolone. Acta chir. scand., 124; 163 (1962).
12.
EricG. C.: Essai experimental du corps 84-04 C en ionisation. Cahiers d'électrothérapie, 1; 7 (1970).
13.
Fogh-AndersenP.: Surgical treatment of plastic induration of the penis (Peyronic's disease). Acta cir. scand., 113; 45 (1957).
14.
FrankI. N., ScottW. W.: The ultrasonic treatment of Peyronie's disease. J. Urol., 106; 83 (197).
15.
FureyC. A.Jr.: Peyronie's disease: treatment by the local injection of metilcortelone and hydrocortisone. J. Urol., 77; 251 (1957).
16.
GalliziaF.: Triade collagène: maladie de La Peyronie, maladie de Dupuytren et fibrose du cartilage auriculaire. J. d'Urol., 70; 424 (1964).
17.
GraffL. C.: Peyronie's disease. The role of radiation therapy and a general review. Amer. J. Roentgenol., 100; 916 (1967).
18.
Hasche-KlünderR.: À propos du traitement de l'induration plastique des corps caverneux. Acta urol. belg., 38; 516 (1970).
19.
LowsleyO. S., BoceW. H.: Further experiences with operation of cure of Peyronie's disease. J. Urol., 63; 888 (1950).
20.
PoutasseE. F.: Peyronie's disease. J. Urol., 107; 419 (1972).
21.
RenaultP. F.: L'ionisation de Thiomucase en reéducation functionelle. Rev. méd. Normandes, 8; 263 (1966).
22.
ScheinmanL. J., MullerE. V.: Use of dimethyl sulfoxide (DMSO) in Peyronie's disease: a preliminary report. Pacific Medicine & Surgery, 75; 61 (1967).
23.
ScottW. W., ScardinoP. L.: New concept in treatment of Peyronie's disease. South. med. J., 41; 173 (1948).
TaboadaA., Yañez SalmeronM., De MelloE.: Traitement précoce des oedèmes post-traumatiques et post-chirurgicaux par ionophorèse (dépolimérisation enzymatique). Prensa med. argen., 57; 1788 (1970).
27.
TeasleyG. H.: Peyronie's disease: new approach. J. Urol., 71; 611 (1954).
28.
ToksuE.: Peyronie's disease: a method of treatment. J. Urol., 105; 523 (1971).
29.
WilliamsJ. L., ThomasG. G.: The natural history of Peyronie's disease. J. Urol., 103; 75 (1970).
30.
ZanettaM., TrezziM., AgusG. B.: Trattamento degli edemi degli arti inferiori di origine vascolare mediante ionoforesi. Minerva cardioangiol. (in corso di stampa).
31.
ZarafonetisC. J. D., HorraxT. M.: Treatment of Peyronie's disease with paraminobenzoate (POTABA). J. Urol., 81; 770 (1959).
32.
ZarafonetisC. J. D.: Antifibrotic therapy with POTABA. Amer. J. med. Sci., 248; 550 (1964).
